The Hidden Danger of IgAN: Pathogenesis and Unmet Needs
Jonathan Barratt, MD, PhD
Unmasking IgAN: Achieving Earlier Diagnosis
An De Vriese, MD, PhD
Navigating KDIGO Guidance in IgAN
Jörg Latus, MD
Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN
Chee Kay Cheung, MBChB, MRCP, PhD
Translating Evidence into IgAN Care
The Future of IgAN Care
The Evolving Role of Biomarkers in IgAN
Spotlight on Assessment: Tools That Capture CKD-aP
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN
When Itching Hurts: Quality of Life Disruption in CKD-aP
Nancy Helou, PhD
Steven Fishbane, MD
From Scratch to Strategy: Talking About CKD-aP in Clinical Practice
Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
Antoine Lanot, MD, PhD
Gil Yosipovitch, MD
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Ellie Kelepouris, MD, FACP, FAHA
Nihar R. Desai, MD, MPH
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Maurizio Gallieni, MD
The Patient-Clinician Connection in Managing CKD-aP
James Burton, DM, FRCP
Lucio Manenti, MD, PhD
Decoding Itch in CKD: From CKD-aP Suspicion to Solution
Leonie Kraft, MD
Emilio Sanchez, MD, PhD
CKD-aP or Something Else? Decoding the Diagnosis
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.